{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:39:39Z","timestamp":1783420779393,"version":"3.54.6"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Sophisticated cancer treatments, cardiovascular risk factors, and aging trigger acute cardiovascular diseases in an increasing number of cancer patients. Among acute cardiovascular diseases, cancer treatment, as well as the cancer disease itself, may induce a cardiogenic shock. Although increasing, these cardiogenic shocks are still relatively limited, and their management is a matter of debate in cancer patients. Etiologies that cause cardiogenic shock are slightly different from those of non-cancer patients, and management has some specific features always requiring a multidisciplinary approach. Recent guidelines and extensive data from the scientific literature can provide useful guidance for the management of these critical patients. Even if no etiologic therapy is available, maximal intensive supportive measures can often be justified, as most of these cardiogenic shocks are potentially reversible. In this review, we address the major etiologies that can lead to cardiogenic shock in cancer patients and discuss issues related to its management.<\/jats:p>","DOI":"10.3389\/fcvm.2022.932400","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:42:17Z","timestamp":1661150537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiogenic shock among cancer patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Anais","family":"Curtiaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Gantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Siegemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Merdji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (pure): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","article-title":"Progress in cancer mortality, incidence, and survival: a global overview","volume":"29","author":"Santucci","year":"2020","journal-title":"Eur J Cancer Prev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41467-020-15639-5","article-title":"Fatal heart disease among cancer patients","volume":"11","author":"Stoltzfus","year":"2020","journal-title":"Nat Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40959-021-00110-1","article-title":"A new classification of cardio-oncology syndromes","volume":"7","author":"de Boer","year":"2021","journal-title":"Cardiooncology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"155850","DOI":"10.1016\/j.cyto.2022.155850","article-title":"Interleukin-1 (Il-1) and the Inflammasome in Cancer","volume":"153","author":"Pretre","year":"2022","journal-title":"Cytokine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3332\/ecancer.2008.126","article-title":"Cardio-oncology: a new medical issue","volume":"2","author":"Cardinale","year":"2008","journal-title":"Ecancermedicalscience."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: rationale, organization, and implementation","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrcardio.2016.96","article-title":"Management of refractory cardiogenic shock","volume":"13","author":"Reyentovich","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","article-title":"A standardized and comprehensive approach to the management of cardiogenic shock","volume":"8","author":"Tehrani","year":"2020","journal-title":"JACC Heart Fail."},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/ehjacc\/zuab056","article-title":"Evaluation and management of cancer patients presenting with acute cardiovascular disease: a consensus document of the acute cardiovascular care (ACVC) association and the esc council of cardio-oncology-part 1: acute coronary syndromes and acute pericardial diseases","volume":"10","author":"Gevaert","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ehf2.13734","article-title":"Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the frenshock registry","volume":"9","author":"Delmas","year":"2022","journal-title":"ESC Heart Fail."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e001462","DOI":"10.1161\/JAHA.114.001462","article-title":"Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock","volume":"4","author":"Shaefi","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"A693","DOI":"10.1016\/S0735-1097(18)31234-8","article-title":"The effect of cancer on outcomes of acute heart failure exacerbations: a 5-year nationwide analysis","volume":"71","author":"Rodriguez","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6=.5 million patients with a current or historical diagnosis of cancer in the USA.","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with Cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/106002809402800314","article-title":"Fluorouracil cardiotoxicity","volume":"28","author":"Anand","year":"1994","journal-title":"Ann Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new\u2013an evolving avenue","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"590016","DOI":"10.3389\/fcvm.2021.590016","article-title":"Challenges and management of acute coronary syndrome in cancer patients","volume":"8","author":"Costa","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcmg.2018.04.028","article-title":"Radiation-associated cardiac disease: a practical approach to diagnosis and management","volume":"11","author":"Desai","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e021686","DOI":"10.1161\/JAHA.121.021686","article-title":"Radiation-induced cardiovascular disease: review of an underrecognized pathology","volume":"10","author":"Belzile-Dugas","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCA.0000000000000429","article-title":"Long-term outcomes after percutaneous coronary interventions in cancer survivors","volume":"28","author":"Landes","year":"2017","journal-title":"Coron Artery Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/ehjqcco\/qcy014","article-title":"Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an observation from coronary revascularization demonstrating outcome study-kyoto registry cohort-2)","volume":"4","author":"Nakatsuma","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246203","article-title":"Acute and long-term outcomes of st-elevation myocardial infarction in cancer patients, a 'real world' analysis with 175,000 patients","volume-title":"Cancers (Basel).","author":"Lange","year":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"758324","DOI":"10.3389\/fcvm.2022.758324","article-title":"A concomitant cancer diagnosis is associated with poor cardiovascular outcomes among acute myocardial infarction patients","volume":"9","author":"Peng","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphys.2018.01294","article-title":"Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach","volume":"9","author":"Madeddu","year":"2018","journal-title":"Front Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11912-018-0724-8","article-title":"Acute coronary syndrome management in cancer patients","volume":"20","author":"Al-Hawwas","year":"2018","journal-title":"Curr Oncol Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","article-title":"the impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J Clin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0049-3848(14)50011-4","article-title":"Thrombocytopenia in cancer patients","volume":"2","author":"Liebman","year":"2014","journal-title":"Thromb Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5114\/wo.2012.31766","article-title":"Acute pulmonary embolus in the course of cancer","volume":"16","author":"Biedka","year":"2012","journal-title":"Contemp Oncol (Pozn)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1160\/TH09-06-0397","article-title":"Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient dvt clinics","volume":"103","author":"Paneesha","year":"2010","journal-title":"Thromb Haemost."},{"key":"B37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjmed.2016.10.017","article-title":"The clinical course of venous thromboembolism may differ according to cancer site","volume":"130","author":"Mahe","year":"2017","journal-title":"Am J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers."},{"key":"B39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.thromres.2011.10.025","article-title":"Anticancer treatment and thrombosis","volume":"129","author":"Falanga","year":"2012","journal-title":"Thromb Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41598-020-58345-4","article-title":"Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis","volume":"10","author":"Junjun","year":"2020","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2017.09.045","article-title":"Neoplastic embolization to systemic and pulmonary arteries","volume-title":"J Vasc Surg.","author":"Bois","year":"2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/682225","article-title":"Acute pulmonary hypertension caused by tumor embolism: a report of two cases","volume":"5","author":"Mury","year":"2015","journal-title":"Pulm Circ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000081340","article-title":"Disseminated microvascular pulmonary tumor cell embolism: a rare cause of fulminant pulmonary hypertension","volume":"27","author":"Steiner","year":"2004","journal-title":"Onkologie."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12890-021-01808-9","article-title":"Outcomes of acute pulmonary embolism in hospitalized patients with cancer","volume":"22","author":"Shalaby","year":"2022","journal-title":"BMC Pulm Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11239-020-02298-y","article-title":"Clinical presentations and outcomes in pulmonary embolism patients with cancer","volume":"51","author":"Au","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 Esc guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (Ers)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11739-016-1431-9","article-title":"Clinical presentation and in-hospital death in acute pulmonary embolism: does cancer matter?","volume":"11","author":"Casazza","year":"2016","journal-title":"Intern Emerg Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11239-018-1772-5","article-title":"Comorbid cancer and use of thrombolysis in acute pulmonary embolism","volume":"47","author":"Weeda","year":"2019","journal-title":"J Thromb Thrombolysis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0735-1097(22)01592-3","article-title":"Outcomes of cancer patients with pulmonary embolism treated with thrombolysis therapy or thrombectomy","volume":"22","author":"Waqas Ullah","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.acvd.2020.06.002","article-title":"Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: a position paper from the \u201cunite de soins intensifs de cardiologie\u201d group of the french society of cardiology","volume":"113","author":"Delmas","year":"2020","journal-title":"Arch Cardiovasc Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"I22","DOI":"10.1161\/01.CIR.0000078464.82671.78","article-title":"Natural history of venous thromboembolism","volume":"107","author":"Kearon","year":"2003","journal-title":"Circulation."},{"key":"B52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1358863X18754692","article-title":"Short- and long-term mortality after pulmonary embolism in patients with and without cancer","volume":"23","author":"Alotaibi","year":"2018","journal-title":"Vasc Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3324\/haematol.2018.192419","article-title":"Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer","volume":"103","author":"Grilz","year":"2018","journal-title":"Haematologica."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3324\/haematol.2018.197814","article-title":"Arterial thrombosis and cancer: the neglected side of the coin of trousseau syndrome","volume":"103","author":"De Stefano","year":"2018","journal-title":"Haematologica."},{"key":"B55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: esmo consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 Esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (Esc)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: american society of clinical oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e018403","DOI":"10.1161\/JAHA.120.018403","article-title":"Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the american and european cardio-oncology guidelines","volume":"9","author":"Alexandre","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"713694","DOI":"10.3389\/fcvm.2021.713694","article-title":"Severe cardiac toxicity induced by cancer therapies requiring intensive care unit admission","volume":"8","author":"Montisci","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation."},{"key":"B61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fcvm.2020.00035","article-title":"Mechanisms of anthracycline-induced cardiotoxicity: is mitochondrial dysfunction the answer?","volume":"7","author":"Murabito","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The sglt-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000480291","article-title":"Cardiogenic shock during first infusion of anthracycline chemotherapy in a patient with hodgkin lymphoma: an unusual event","volume":"139","author":"Binaghi","year":"2018","journal-title":"Cardiology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.healun.2008.10.002","article-title":"Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device","volume":"28","author":"Freilich","year":"2009","journal-title":"J Heart Lung Transplant."},{"key":"B66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0391398818772497","article-title":"Recovery from anthracycline-induced cardiomyopathy with biventricular assist and valve repairs: a case report and literature review","volume":"41","author":"Takami","year":"2018","journal-title":"Int J Artif Organs."},{"key":"B67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11912-021-01114-x","article-title":"Cardiovascular toxicity of novel her2-targeted therapies in the treatment of breast cancer","volume":"23","author":"Dent","year":"2021","journal-title":"Curr Oncol Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1200\/OP.20.00924","article-title":"Monitoring for chemotherapy-related cardiotoxicity in the form of left ventricular systolic dysfunction: a review of current recommendations","volume":"17","author":"Stone","year":"2021","journal-title":"JCO Oncol Pract."},{"key":"B69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tschope","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B70","first-page":"861","article-title":"5-fluorouracil related toxic myocarditis: case reports and pathological confirmation","volume":"10","author":"Sasson","year":"1994","journal-title":"Can J Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","article-title":"Cardiotoxicity associated with high-dose cyclophosphamide therapy","volume":"141","author":"Gottdiener","year":"1981","journal-title":"Arch Intern Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"17324","DOI":"10.1038\/s41598-021-96467-5","article-title":"Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data","volume":"11","author":"Makunts","year":"2021","journal-title":"Sci Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI145186","article-title":"Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms","volume":"131","author":"Moslehi","year":"2021","journal-title":"J Clin Invest."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/a-0669-9556","article-title":"Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease?","volume":"51","author":"Santos","year":"2019","journal-title":"Horm Metab Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13613-016-0219-4","article-title":"Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock","volume":"6","author":"Hekimian","year":"2016","journal-title":"Ann Intensive Care."},{"key":"B78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4065\/77.1.92","article-title":"Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency","volume":"77","author":"Laufs","year":"2002","journal-title":"Mayo Clin Proc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amjms.2017.04.002","article-title":"Eosinophilic myocarditis","volume":"354","author":"Cheung","year":"2017","journal-title":"Am J Med Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12020-019-02035-3","article-title":"Pheochromocytoma- and paraganglioma-triggered takotsubo syndrome","volume":"65","author":"S","year":"2019","journal-title":"Endocrine."},{"key":"B81","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of Takotsubo Syndrome","volume":"135","author":"Pelliccia","year":"2017","journal-title":"Circulation."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/eurheartj\/ehy077","article-title":"International expert consensus document on Takotsubo Syndrome (Part Ii): diagnostic workup, outcome, and management","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/FJC.0000000000001026","article-title":"Takotsubo cardiomyopathy as epiphenomenon of cardiotoxicity in patients with cancer: a meta-summary of case reports","volume":"78","author":"Carbone","year":"2021","journal-title":"J Cardiovasc Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijcard.2017.02.093","article-title":"Prevalence of cancer in takotsubo cardiomyopathy: short and long-term outcome","volume":"238","author":"Sattler","year":"2017","journal-title":"Int J Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ejheart.2008.07.008","article-title":"Long-term prognosis of the transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): focus on malignancies","volume":"10","author":"Burgdorf","year":"2008","journal-title":"Eur J Heart Fail."},{"key":"B87","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/eurjhf\/hfp076","article-title":"Activated cell survival cascade protects cardiomyocytes from cell death in tako-tsubo cardiomyopathy","volume":"11","author":"Nef","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.ijcard.2013.03.050","article-title":"Polymorphisms of the antiapoptotic protein bag3 may play a role in the pathogenesis of tako-tsubo cardiomyopathy","volume":"168","author":"Citro","year":"2013","journal-title":"Int J Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10741-019-09773-6","article-title":"Malignancies and outcome in takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy","volume":"24","author":"Brunetti","year":"2019","journal-title":"Heart Fail Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e010881","DOI":"10.1161\/JAHA.118.010881","article-title":"Clinical features and outcomes of patients with malignancy and takotsubo syndrome: observations from the international takotsubo registry","volume":"8","author":"Cammann","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00432-018-2661-1","article-title":"Outcomes of Takotsubo Cardiomyopathy in hospitalized cancer patients","volume":"144","author":"Joy","year":"2018","journal-title":"J Cancer Res Clin Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.amjcard.2018.11.054","article-title":"Usefulness of malignancy as a predictor of worsein-hospital outcomes in patients with takotsubo cardiomyopathy","volume":"123","author":"Zaghlol","year":"2019","journal-title":"Am J Cardiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2020.02.036","article-title":"National prevalence, trends and outcomes of takotsubo syndrome in hospitalizations with prior history of mediastinal\/intrathoracic cancer and radiation therapy","volume":"309","author":"Desai","year":"2020","journal-title":"Int J Cardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40959-019-0053-6","article-title":"Antecedent cancer in takotsubo syndrome predicts both cardiovascular and long-term mortality","volume":"5","author":"Nguyen","year":"2019","journal-title":"Cardiooncology."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.amjcard.2017.09.009","article-title":"Stress-induced cardiomyopathy in cancer patients","volume":"120","author":"Giza","year":"2017","journal-title":"Am J Cardiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijcard.2016.07.246","article-title":"What is\/are the trigger(s) of takotsubo syndrome in cancer patients receiving chemotherapy?","volume":"222","author":"Madias","year":"2016","journal-title":"Int J Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40959-019-0042-9","article-title":"Takotsubo cardiomyopathy in cancer patients","volume":"5","author":"Desai","year":"2019","journal-title":"Cardiooncology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1056\/NEJMc1512595","article-title":"Takotsubo (Stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1471-2261-14-147","article-title":"Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: a two-year, two-center experience","volume":"14","author":"De Backer","year":"2014","journal-title":"BMC Cardiovasc Disord."},{"key":"B100","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-21-0373","article-title":"Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy","volume-title":"Endocr Relat Cancer.","author":"Amar","year":"2022"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion.","volume":"66","author":"El Haddad","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/icvts\/ivu267","article-title":"Palliative treatment for symptomatic malignant pericardial effusiondagger","volume":"19","author":"Jama","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"B103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1477-7819-12-249","article-title":"Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery","volume":"12","author":"Jeon","year":"2014","journal-title":"World J Surg Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/clc.22295","article-title":"Primary malignancies of the heart and pericardium","volume":"37","author":"Burazor","year":"2014","journal-title":"Clin Cardiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jrr\/rry029","article-title":"Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique","volume":"59","author":"Takata","year":"2018","journal-title":"J Radiat Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11936-018-0654-7","article-title":"Pericardial disease in cancer patients","volume":"20","author":"Ghosh","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11886-019-1225-6","article-title":"Cancer treatment-associated pericardial disease: epidemiology, clinical presentation, diagnosis, and management","volume":"21","author":"Ala","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 Esc guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the european society of cardiology (Esc)endorsed by: the european association for cardio-thoracic surgery (Eacts)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcmg.2017.06.017","article-title":"Effusive-constrictive pericarditis after pericardiocentesis: incidence, associated findings, and natural history","volume":"11","author":"Kim","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B111","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/2048872614547975","article-title":"Patient characteristics and predictors of mortality associated with pericardial decompression syndrome: a comprehensive analysis of published cases","volume":"4","author":"Pradhan","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"B112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1010-7940(00)00612-6","article-title":"Cardiac dislocation after extended pneumonectomy with pericardioplasty","volume":"19","author":"Veronesi","year":"2001","journal-title":"Eur J Cardiothorac Surg."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/00000658-194811000-00021","article-title":"Herniation of the heart: through a pericardial incision","volume":"128","author":"Bettman","year":"1948","journal-title":"Ann Surg."},{"key":"B114","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajem.2022.01.017","article-title":"Cardiac herniation: a practical review in the emergency setting","volume":"53","author":"Scagliola","year":"2022","journal-title":"Am J Emerg Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1177\/0218492315589199","article-title":"Cardiac herniation after left intrapericardial pneumonectomy","volume":"24","author":"Alimi","year":"2016","journal-title":"Asian Cardiovasc Thorac Ann."},{"key":"B116","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4103\/ijccm.IJCCM_60_17","article-title":"Cardiac herniation with torsion after right pneumonectomy","volume":"21","author":"Schummer","year":"2017","journal-title":"Indian J Crit Care Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0003-4975(03)01404-8","article-title":"Sudden cardiac herniation 6 months after right pneumonectomy","volume":"78","author":"Zandberg","year":"2004","journal-title":"Ann Thorac Surg."},{"key":"B118","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00000542-198404000-00016","article-title":"Management of cardiac herniation after intrapericardial pneumonectomy","volume":"60","author":"Cassorla","year":"1984","journal-title":"Anesthesiology."},{"key":"B119","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jacc.2018.05.026","article-title":"Neoplasia and the heart: pathological review of effects with clinical and radiological correlation","volume":"72","author":"Maleszewski","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5114\/kitp.2022.114553","article-title":"Surgical treatment of primary cardiac tumors: 20-year single center experience","volume":"19","author":"Dergel","year":"2022","journal-title":"Kardiochir Torakochirurgia Pol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12885-018-4070-x","article-title":"Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment","volume":"18","author":"Burazor","year":"2018","journal-title":"BMC Cancer."},{"key":"B122","article-title":"Cardiac metastases","volume-title":"Cancer.","author":"Klatt","year":"1990"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e016032","DOI":"10.1161\/JAHA.120.016032","article-title":"Primary malignant cardiac tumors: a rare disease with an adventurous journey","volume":"9","author":"Gupta","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B124","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0002-9149(97)00587-0","article-title":"Primary and secondary neoplasms of the heart","volume":"80","author":"Roberts","year":"1997","journal-title":"Am J Cardiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11886-020-01420-z","article-title":"Cardiac tumors: diagnosis, prognosis, and treatment","volume":"22","author":"Bussani","year":"2020","journal-title":"Curr Cardiol Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaccao.2020.05.009","article-title":"Cardiac tumors: jacc cardiooncology state-of-the-art review","volume":"2","author":"Tyebally","year":"2020","journal-title":"JACC CardioOncol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular disease among adults with cancer","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC: CardioOncology."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1161\/CIRCULATIONAHA.118.039180","article-title":"Representation of patients with cardiovascular disease in pivotal cancer clinical trials","volume":"139","author":"Bonsu","year":"2019","journal-title":"Circulation."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","article-title":"The intensive care medicine research agenda on critically ill oncology and hematology patients","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00134-016-4563-5","article-title":"The effects of performance status one week before hospital admission on the outcomes of critically ill patients","volume":"43","author":"Zampieri","year":"2017","journal-title":"Intensive Care Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00134-022-06617-0","article-title":"Impact of frailty on persistent critical illness: a population-based cohort study","volume":"48","author":"Darvall","year":"2022","journal-title":"Intensive Care Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cjco.2021.03.009","article-title":"Prevalence and prognosis impact of frailty among older adults in cardiac intensive care units","volume":"3","author":"Volle","year":"2021","journal-title":"CJC Open."},{"key":"B133","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jamaoncol.2015.3336","article-title":"Time-Limited trials of intensive care for critically ill patients with cancer: how long is long enough?","volume":"2","author":"Shrime","year":"2016","journal-title":"JAMA Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ehjacc\/zuab015","article-title":"Joint eapci\/acvc expert consensus document on percutaneous ventricular assist devices","volume":"10","author":"Chieffo","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"B135","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The role of cardioprotection in cancer therapy cardiotoxicity: jacc: cardiooncology state-of-the-art review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC CardioOncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/nu10091304","article-title":"Cardioprotective effects of nanoemulsions loaded with anti-inflammatory nutraceuticals against doxorubicin-induced cardiotoxicity","volume":"10","author":"Quagliariello","year":"2018","journal-title":"Nutrients."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.932400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T06:42:23Z","timestamp":1661150543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.932400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":136,"alternative-id":["10.3389\/fcvm.2022.932400"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.932400","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"932400"}}